The Coalition for Healthcare Communications (CHC) called on the FDA to simplify guidelines for DTC advertising.
FDA alerted on abort drug
May 1, 2006
9:02 pm
The FDA says it is investigating two more US deaths associated with the medical abortion drug Mifeprex (mifepristone) that were recently reported to the agency by the manufacturer, Danco Laboratories.
Ex-HHS deputy Allen in fraud arrest
May 1, 2006
8:59 pm
Claude Alexander Allen, the No. 2 Bush appointee at the Department of Health and Human Services (HHS), was arrested in March for allegedly swindling retail stores out of more than $5,000 in 25 fraudulent refunds since January.
Off-label prosecutors target devices
May 1, 2006
8:57 pm
In what may signal a new wave of government investigations, the US Attorney’s Office in Philadelphia has issued a grand jury subpoena to a device firm–PA-based Synthes–over alleged off-label promotion practices.
Before he left the FDA 18 months ago, former chief counsel Dan Troy failed to complete a necessary legal review of Barr Laboratories’ proposed under-16 sales restriction on over-the-counter Plan B, requested by FDA reviewers eight months earlier, according to a March 9 letter to the agency from Henry A. Waxman (D-CA).
DTC spending may have hit a plateau, according to research firm Optas, but integrated direct-to-patient programs combining in-office, e-mail and Web channels will see significant growth.
Abbott Laboratories, followed by Johnson & Johnson and Eli Lilly, were ranked the top pharma companies in overall sales force quality by primary care physicians, according to TargetRx’s “Sales Force Analysis” report.
Loading...
MM+M Transform: The Patient, Provider and Payer Engagement Matrix